E00.1
Congenital iodine-deficiency syndrome, myxedematous type
Clinical Classification Guidelines
Inclusion Terms
- Endemic hypothyroid cretinism
- Endemic cretinism, myxedematous type
Medical Intelligence & Overview
Congenital iodine-deficiency syndrome, myxedematous type, also known as endemic hypothyroid cretinism, is a condition present at birth caused by a severe lack of iodine in the environment. This deficiency impairs the development and functioning of the thyroid gland, leading to a range of developmental and health issues. The condition is most common in regions where iodine deficiency is widespread and can significantly affect physical and neurological growth if not diagnosed and managed early.
Causes & Symptoms
Clinical Causes: Insufficient iodine intake in the mother's diet during pregnancy Living in areas with endemic iodine deficiency, such as mountainous regions or inland areas far from the sea Poor iodine nutrition due to inadequate access to iodized salt or iodine-rich foods Maternal health issues that impair iodine transfer to the fetus
Key Symptoms: Stunted physical growth and delayed development Myxedematous skin changes, including thickened, dry skin Intellectual disability or developmental delays Hearing and speech impairments Facial abnormalities such as macroglossia (enlarged tongue) and flattened nasal bridge Delayed bones and skeletal maturation Lethargy and low energy levels Protruding abdomen and umbilical hernia
Diagnostic & Treatment
Diagnosis Path: Diagnosis of congenital iodine-deficiency syndrome is made based on clinical evaluation and developmental history. Key steps include: - Newborn screening tests that may indicate hypothyroidism - Blood tests measuring levels of thyroid hormones (T3 and T4) and thyroid-stimulating hormone (TSH) - Assessing maternal iodine status during pregnancy - Imaging studies such as ultrasound of the thyroid gland to evaluate its size and structure - Developmental assessments to evaluate cognitive and motor skills Early detection through newborn screening is critical to prevent long-term disabilities and enable timely intervention.
Treatment Protocols: Management strategies focus on correcting hypothyroidism and addressing developmental delays: - Initiation of thyroid hormone replacement therapy, typically with levothyroxine, as early as possible - Nutritional support including iodine supplementation to prevent further deficiency - Regular monitoring of thyroid function to adjust medication dosages - Early intervention programs for speech, physical, and occupational therapy - Educational support tailored to the child's developmental needs Preventive measures include ensuring adequate iodine intake for pregnant women through diet and salt iodization programs, which have proven effective in reducing incidence in endemic regions.
Clinical Advice & FAQs
Billing Guidance
Is E00.1 a billable ICD-10 code?
Yes, E00.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E00.1?
Clinical documentation must specify the nature of Congenital iodine-deficiency syndrome, myxedematous type and any associated comorbidities for accurate reporting.
Cite this Clinical Reference